Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

An2-conjugated anti-HER2 MAb and MAb-drug conjugates designed to cross BBB

Dec. 24, 2014

Novel biomarker described for Alzheimer's disease

Dec. 24, 2014

First-in-class BRD2/3/4 inhibitor OTX-015, a potential broad-spectrum anticancer drug

Dec. 24, 2014

NETRIS Pharma creates first humanized monoclonal antibody against netrin-1

Dec. 23, 2014

MYL3 gene mutation identified in hypertrophic cardiomyopathy pedigree

Dec. 23, 2014

Morphine tolerance reversed by blocking neuropeptide FF2 receptor

Dec. 23, 2014

Researchers report phase I results on taselisib in breast cancer

Dec. 22, 2014

Further phase III data reveal efficacy of LCZ-696 in hypertension and heart failure

Dec. 22, 2014

Takeda describes PDE10A inhibitor TAK-063

Dec. 22, 2014

Report of phase I evaluation of a STAT3 ASO for hepatocellular carcinoma

Dec. 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...